Benoit Barteau

Benoit Barteau is an experienced board member actively involved in the biotechnology sector, serving on the boards of multiple companies including Eligo Bioscience, Flamingo Therapeutics, Tridek-One, Meiogenix, BrainEver, Alentis Therapeutics, and Igyxos. With expertise in areas such as RNA therapeutics, gene editing, and advanced liver diseases, Benoit focuses on developing innovative treatments for various medical conditions. Benoit has held the position of Director of Life Sciences at Bpifrance since May 2014, overseeing several funds aimed at advancing biotechnology. Educational credentials include a PhD in Immunology and Biotechnology from Nantes Université and a Master’s in Finance from IAE Paris - Sorbonne Business School.